Keyphrases
Adult Patients
21%
Aging Male Symptoms
21%
Axillary Lymph Node Dissection
25%
Azoospermic Men
20%
Bile Duct
24%
Bradykinin
28%
C-type Natriuretic Peptide
28%
Clinical Response
35%
COVID-19
71%
Cyclic Adenosine Monophosphate (cAMP)
24%
Cyclic GMP
32%
Cyclic nucleotide Phosphodiesterase
35%
Decompensated Cirrhosis
47%
Decompression
29%
Endothelin-1 (ET-1)
25%
Erectile Dysfunction
55%
Expression Response
20%
External Validation
25%
Genetic Polymorphism
35%
Granulocyte Colony-stimulating Factor (G-CSF)
53%
Hepatocyte Apoptosis
35%
Immediate Lymphatic Reconstruction
21%
Indonesia
100%
Indonesian
59%
Intervention Group
23%
Isoenzymes
43%
Jakarta
47%
Liver Transplantation
37%
Locally Advanced
25%
Lymphedema Treatment
35%
Lymphovenous Anastomosis
25%
Melatonin
29%
Neoadjuvant Chemotherapy
35%
Non-communicable Diseases
20%
Nutritional Status
22%
Obstructive Jaundice
35%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
35%
Pediatric
53%
Pediatric End-stage Liver Disease
30%
Phosphodiesterase
53%
Phosphodiesterase Inhibitors
33%
Pretransplant
20%
Randomized Controlled Trial
61%
Relaxation Effect
28%
Risk Factors
28%
Sildenafil
23%
Smooth muscle
80%
Ureter
29%
Vasoactive Intestinal Polypeptide
30%
Y Chromosome Microdeletion
20%
Medicine and Dentistry
Alpha Adrenergic Receptor Blocking Agent
17%
Andropause
17%
Axillary Lymph Node
21%
Azoospermia
22%
Bile
17%
Bile Duct
17%
Breast Cancer
25%
Breast Cancer-Related Lymphedema
17%
Cancer Therapy
21%
Chronic Pelvic Pain Syndrome
17%
Chronic Prostatitis
17%
Clinical Examination
17%
Combination Therapy
29%
COVID-19
42%
Cyclic Nucleotide Phosphodiesterase
35%
Decompensated Liver Cirrhosis
47%
Diabetes Mellitus
28%
End Stage Liver Disease
30%
Erectile Dysfunction
55%
Granulocyte Colony Stimulating Factor
53%
Health System
17%
In Vitro
35%
Innate Immunity
17%
Isoenzyme
26%
Liver Function
18%
Liver Transplantation
37%
Lymph Duct
35%
Lymphedema
28%
Male Infertility
17%
Malignant Neoplasm
21%
Melatonin
17%
microRNA 210
17%
Monotherapy
17%
Neoadjuvant Chemotherapy
17%
Nitric Oxide Donor
17%
Nutritional Status
22%
Obstructive Jaundice
17%
Pediatrics
53%
Phosphodiesterase
35%
Phosphodiesterase Inhibitor
18%
Quality of Life
24%
Randomized Controlled Trial
43%
Retroperitoneal Lymph Node Dissection
21%
Side Effect
18%
Smooth Muscle
35%
Systematic Review
35%
Testis Tumor
22%
Transurethral Resection
17%
Urodilatin
17%
Urology
20%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Adrenergic Receptor Blocking Agent
17%
Big Endothelin 1
15%
Bile Acid
17%
Bradykinin
35%
Chemotherapy
35%
Chronic Prostatitis
17%
Combination Therapy
30%
Cross-Sectional Study
19%
Cyclic AMP
25%
Cyclic GMP
35%
Cyclic Nucleotide
15%
Cyclic Nucleotide Phosphodiesterase
35%
Decompensated Liver Cirrhosis
29%
End Stage Liver Disease
18%
Endothelin 1
18%
Erectile Dysfunction
37%
Granulocyte Colony Stimulating Factor
35%
Hydrocortisone
17%
Hypoxia Inducible Factor
17%
Hypoxia Inducible Factor 1
15%
Isoenzyme
44%
Kidney Stone
17%
Lower Urinary Tract Symptom
17%
Male Infertility
17%
Malignant Neoplasm
17%
Melatonin
35%
microRNA 210
17%
Monotherapy
17%
Mouth Squamous Cell Carcinoma
35%
Natriuretic Peptide Type C
35%
Neoplasm
15%
Nephrolithiasis
17%
Obstructive Jaundice
35%
Pelvis Pain Syndrome
17%
Phosphodiesterase
53%
Phosphodiesterase Inhibitor
36%
Phosphodiesterase V Inhibitor
21%
Premature Ejaculation
17%
Proteinase
17%
Randomized Clinical Trial
17%
Randomized Controlled Trial
42%
Recurrent Disease
17%
Selective Serotonin Reuptake Inhibitor
17%
Serotonin Reuptake Inhibitor
17%
Sildenafil
17%
Tablet
16%
Tolerability
17%
Urodilatin
17%
Vardenafil
17%
Vasoactive Intestinal Polypeptide
33%
